Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:27 AM
Ignite Modification Date:
2025-12-25 @ 3:27 AM
NCT ID:
NCT03819205
Eligibility Criteria:
Inclusion Criteria:
1. Age between 6-18
2. Following up with diagnose of hemiplegic/diplegic/tetraplegic CP patients with current imaginig findings
3. Patient with stable clinical status
4. Stage ≤2 patients depended on the modified ascwort scale
5. Patients who are eligible to participate the study tests with suitable cognitive state
6. Patients who agreed to participate the study.
Exclusion Criteria:
1. Stage \>2 patients depended on the modified ascwort scale
2. Botilinum toxin intervention to the upper extremity in the last 6 months.
3. Patients who undergo upper extremity surgery.
4. Patients who have contraindication for kinesiotaping (Wide and severe skin injury, open wounds at risk of infection , allergic reactions)
5. Patients with intense sensory and motor loss in the banding area
6. Patients classified in stage IIB and above according to Zancolli stage
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
6 Years
Maximum Age:
18 Years
Study:
NCT03819205
Study Brief:
Protocol Section:
NCT03819205